<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 20-year-old woman with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> underwent bone marrow transplantation from an HLA-identical sibling after total lymphoid irradiation (TLI) and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (CY) </plain></SENT>
<SENT sid="1" pm="."><plain>The post-transplant course was uneventful </plain></SENT>
<SENT sid="2" pm="."><plain>CYA was discontinued on day 221 </plain></SENT>
<SENT sid="3" pm="."><plain>Three weeks later, the patient developed cutaneous GVHD precisely localized to the field of TLI </plain></SENT>
<SENT sid="4" pm="."><plain>No other organs were involved </plain></SENT>
<SENT sid="5" pm="."><plain>Immunohistochemical staining of the affected skin was strongly positive for ICAM-1, PECAM-1 and ELAM-1; <z:mpath ids='MPATH_458'>normal</z:mpath> skin was only weakly positive for ICAM-1 </plain></SENT>
<SENT sid="6" pm="."><plain>CYA was restarted, and the <z:mp ids='MP_0001212'>skin lesions</z:mp> disappeared </plain></SENT>
<SENT sid="7" pm="."><plain>TLI may contribute to an unusual presentation of cutaneous GVHD associated with specific expression of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules </plain></SENT>
</text></document>